LabCompass

Renzhi Han

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID
Muscle Physiology and DisordersCRISPR and Genetic EngineeringVirus-based gene therapy researchCardiomyopathy and Myosin StudiesIon channel regulation and function

Publications

134

Citations

4,750

Est. group size

—

Recurring co-author estimate

Active years

43

Publishing since 1984

Research summary
AI-generated

Renzhi Han studies gene and genome editing therapies for inherited and metabolic diseases, with a strong focus on Duchenne muscular dystrophy (a genetic muscle-wasting disorder) and related heart complications. The work uses tools such as CRISPR-based editing, base and epigenome editing, and viral gene delivery (for example AAV vectors) in animal models to restore missing proteins or lower disease-causing factors like blood cholesterol and lipids.

Muscular dystrophy and dystrophin rescueTherapeutic gene and base editingEpigenome editing for cholesterol/lipid disordersAAV-based gene deliveryCardiomyopathy and cardiovascular disease models

Publication activity has been fairly steady across the past decade, averaging about 7-8 papers per year over the last five years with some year-to-year fluctuation.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 7.4/year recently
2017: 2 publications172018: 12 publications12182019: 5 publications192020: 10 publications202021: 9 publications212022: 8 publications222023: 4 publications232024: 12 publications12242025: 8 publications252026: 5 publications26
Recent publications
Publishes in
  • Molecular Therapy×12
  • Research Square×6
  • Figshare×6
  • Molecular Therapy — Nucleic Acids×4
  • Nature Communications×3

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile